JP
Therapeutic Areas
Helperby Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| HY001 (cUTI program) | Complicated Urinary Tract Infection (cUTI) | Phase 3 (planned) |
| HY001 (ABSSSI program) | Acute Bacterial Skin and Skin Structure Infections (ABSSSI) | Phase 3 (planned) |